Feasibility of Tablet-Based Patient-Reported Symptom Data Collection Among Hemodialysis Patients.

hemodialysis implementation improvement mixed methods patient-reported outcomes quality symptoms

Journal

Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 05 01 2020
revised: 22 03 2020
accepted: 20 04 2020
entrez: 11 7 2020
pubmed: 11 7 2020
medline: 11 7 2020
Statut: epublish

Résumé

Individuals receiving in-center hemodialysis have high symptom burdens but often do not report their symptoms to care teams. Evidence from other diseases suggest that use of symptom electronic patient-reported outcome measures (ePROMs) may improve outcomes. We assessed the usability of a symptom ePROM system and then implemented a quality improvement (QI) project with the objective of improving symptom communication at a US hemodialysis clinic. During the project, we assessed the feasibility of ePROM implementation and conducted a substudy exploring the effect of ePROM use on patient-centered care. After conducting usability testing, we used mixed methods, guided by the Quality Implementation Framework, to implement a 16-week symptom ePROM QI project. We performed pre-, intra-, and postproject stakeholder interviews to identify implementation barriers and facilitators. We collected ePROM system-generated data on symptoms, e-mail alerts, and response rates, among other factors, to inform our feasibility assessment. We compared pre- and postproject outcomes. There were 62 patient participants (34% black, 16% Spanish-speaking) and 19 care team participants (4 physicians, 15 clinic personnel) at QI project start, and 32 research participants. In total, the symptom ePROM was administered 496 times (completion rate = 84%). The implementation approach and ePROM system were modified to address stakeholder-identified concerns throughout. ePROM implementation was feasible as demonstrated by the program's acceptability, demand, implementation success, practicality, integration in care, and observed trend toward improved outcomes. Symptom ePROM administration during hemodialysis is feasible. Trials investigating the effectiveness of symptom ePROMs and optimal administration strategies are needed.

Identifiants

pubmed: 32647760
doi: 10.1016/j.ekir.2020.04.021
pii: S2468-0249(20)31224-9
pmc: PMC7335968
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1026-1039

Informations de copyright

© 2020 International Society of Nephrology. Published by Elsevier Inc.

Références

BMJ Qual Saf. 2016 Dec;25(12):986-992
pubmed: 26369893
Am J Kidney Dis. 2019 Aug;74(2):167-178
pubmed: 31003865
Kidney Int. 2019 Jul;96(1):37-47
pubmed: 30987837
Ann Fam Med. 2011 Mar-Apr;9(2):155-64
pubmed: 21403143
Clin J Am Soc Nephrol. 2009 Jun;4(6):1057-64
pubmed: 19423570
J Am Soc Nephrol. 2005 Aug;16(8):2487-94
pubmed: 15975996
J Patient Rep Outcomes. 2018 Sep 15;2:42
pubmed: 30294712
Clin J Am Soc Nephrol. 2017 Mar 7;12(3):454-466
pubmed: 28223290
Am J Kidney Dis. 2019 Aug;74(2):148-150
pubmed: 31200974
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8
pubmed: 30798791
Nephrol Dial Transplant. 2018 Oct 1;33(10):1842-1852
pubmed: 29672712
Patient Educ Couns. 2005 Jun;57(3):342-9
pubmed: 15893218
BMC Nephrol. 2017 Dec 06;18(1):356
pubmed: 29212466
Qual Life Res. 2012 Oct;21(8):1305-14
pubmed: 22048932
Med Care. 2000 Feb;38(2):175-86
pubmed: 10659691
J Support Oncol. 2009 May-Jun;7(3):98-9
pubmed: 19507457
J Support Oncol. 2009 May-Jun;7(3):91-7
pubmed: 19507456
Hemodial Int. 2017 Oct;21(4):524-533
pubmed: 27990732
J Am Med Inform Assoc. 2012 May-Jun;19(3):413-22
pubmed: 21828224
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Clin J Am Soc Nephrol. 2007 Sep;2(5):960-7
pubmed: 17702730
Palliat Support Care. 2014 Feb;12(1):69-73
pubmed: 24128592
Health Qual Life Outcomes. 2015 Jan 22;13:2
pubmed: 25608560
J Clin Oncol. 2003 Apr 15;21(8):1536-43
pubmed: 12697878
BMC Health Serv Res. 2013 Jun 11;13:211
pubmed: 23758898
J Fam Pract. 2000 Sep;49(9):796-804
pubmed: 11032203
Can J Kidney Health Dis. 2014 Aug 26;1:22
pubmed: 25960887
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
Qual Life Res. 2016 Mar;25(3):525-34
pubmed: 26790427
BMC Health Serv Res. 2017 Jun 26;17(1):439
pubmed: 28651528
Qual Life Res. 2019 Jan;28(1):253-265
pubmed: 30229532
Value Health. 2019 Oct;22(10):1197-1226
pubmed: 31563263
Am J Community Psychol. 2012 Dec;50(3-4):462-80
pubmed: 22644083

Auteurs

Jennifer E Flythe (JE)

University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, North Carolina, USA.

Matthew J Tugman (MJ)

University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Julia H Narendra (JH)

University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Adeline Dorough (A)

University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Johnathan Hilbert (J)

University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Magdalene M Assimon (MM)

University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Darren A DeWalt (DA)

Division of General Medicine and Clinical Epidemiology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Classifications MeSH